Author

Olorunfemi Ayeotan

Observed names: A. Olorunfemi, Ayeotan Olorunfemi

Institution: Temple University

Observed institutions: Institute of Cancer Research, University College Hospital, Ibadan, Ladoke Akintola University of Technology, Temple University

OpenAlex ID: A5051949615

Acute Toxicity of Hypofractionated and Conventionally Fractionated (Chemo)Radiotherapy Regimens for Bladder Cancer: An Exploratory Analysis from the RAIDER Trial

2023 · R. Huddart, S. Hafeez, et al. · Clinical Oncology · 17

Taurine as Anticancer and Antiviral: Case Report and Prospective Update

2020 · Raúl H Morales-Borges, Michael J González, et al. · 4

Covid-19 Vaccine Benefits and Concerns: Nigerian Perspectives

2021 · Olorunfemi Ayeotan · Journal of Clinical and Medical Research · 2

Abnormal epigenetic aging of epigenetic outliers in normal colon mucosa from colorectal cancer patients

2026 · Bryant M. Schultz, Olorunfemi Ayeotan, et al. · Scientific Reports · 1

Serum Prostatic Specific Antigen Levels among Adult Male Patients Seen at Two Nigerian Tertiary Hospitals

2021 · Agudi Celestine Chibuike, Isaac Medugu Ferdinand, et al. · HAL

The Use of Immune System Cells for The Treatment of Metastatic Cancer: A Personalised Medicine Concept

2021 · Olorunfemi Ayeotan · Journal of Clinical and Medical Research

Works count: 6

Citation count: 24

H-index: 2

I10-index: 1